320 related articles for article (PubMed ID: 29153114)
1. Cost-effectiveness Analyses of Antihypertensive Medicines: A Systematic Review.
Park C; Wang G; Durthaler JM; Fang J
Am J Prev Med; 2017 Dec; 53(6S2):S131-S142. PubMed ID: 29153114
[TBL] [Abstract][Full Text] [Related]
2. Following evidence-based prescribing guidelines for antihypertensives could save big bucks.
Rollins G
Rep Med Guidel Outcomes Res; 2004 Jun; 15(11):1, 6-7. PubMed ID: 15241883
[No Abstract] [Full Text] [Related]
3. Changes in the phamacologic treatment of hypertension in the Department of Veterans Affairs 1997-1999: decreased use of calcium antagonists and increased use of beta-blockers and thiazide diuretics.
Siegel D; Lopez J; Meier J; Cunningham F
Am J Hypertens; 2001 Sep; 14(9 Pt 1):957-62. PubMed ID: 11587164
[TBL] [Abstract][Full Text] [Related]
4. Mild-to-moderate uncomplicated hypertension: further analysis of a cost-effectiveness study of five drugs.
Richter A; Gondek K; Ostrowski C; Dombeck M; Lamb S
Manag Care Interface; 2001 Jul; 14(7):61-9. PubMed ID: 11481819
[TBL] [Abstract][Full Text] [Related]
5. Patterns of prescription antihypertensive drug utilization and adherence to treatment guidelines in the city of Novi Sad.
Tomas A; Tomić Z; Milijasević B; Ban M; Horvat O; Vukmirović S; Sabo A
Vojnosanit Pregl; 2016 Jun; 73(6):531-7. PubMed ID: 27498444
[TBL] [Abstract][Full Text] [Related]
6. Comparative risk of new-onset diabetes mellitus for antihypertensive drugs in elderly: A Bayesian network meta-analysis.
Zhang J; Tong A; Dai Y; Niu J; Yu F; Xu F
J Clin Hypertens (Greenwich); 2019 Aug; 21(8):1082-1090. PubMed ID: 31241860
[TBL] [Abstract][Full Text] [Related]
7. A review of chemical therapies for treating diabetic hypertension.
Sarafidis PA; Alexandrou ME; Ruilope LM
Expert Opin Pharmacother; 2017 Jun; 18(9):909-923. PubMed ID: 28480805
[TBL] [Abstract][Full Text] [Related]
8. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
9. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Chen YJ; Li LJ; Tang WL; Song JY; Qiu R; Li Q; Xue H; Wright JM
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008170. PubMed ID: 30480768
[TBL] [Abstract][Full Text] [Related]
10. Effects of initial antihypertensive drug class on patient persistence and compliance in a usual-care setting in the United States.
Patel BV; Remigio-Baker RA; Mehta D; Thiebaud P; Frech-Tamas F; Preblick R
J Clin Hypertens (Greenwich); 2007 Sep; 9(9):692-700. PubMed ID: 17786070
[TBL] [Abstract][Full Text] [Related]
11. Wealth-related Inequality in Utilization of Antihypertensive Medicines in Iran: an Ecological Study on Population Level Data.
Hashemi-Meshkini A; Kebriaeezadeh A; Jamshidi H; Akbari-Sari A; Rezaei-Darzi E; Mehdipour P; Nikfar S; Farzadfar F
Arch Iran Med; 2016 Feb; 19(2):116-22. PubMed ID: 26838082
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials.
Shahin Y; Khan JA; Samuel N; Chetter I
Atherosclerosis; 2011 May; 216(1):7-16. PubMed ID: 21411098
[TBL] [Abstract][Full Text] [Related]
13. Costs of current antihypertensive therapy in Switzerland: an economic evaluation of 3,489 patients in primary care.
Schäfer HH; Scheunert U
Swiss Med Wkly; 2013; 143():w13854. PubMed ID: 24163048
[TBL] [Abstract][Full Text] [Related]
14. Health outcomes and economic consequences of using angiotensin-converting enzyme inhibitors in comparison with angiotensin receptor blockers in the treatment of arterial hypertension in the contemporary Polish setting.
Wrona W; Budka K; Filipiak KJ; Niewada M; Wojtyniak B; Zdrojewski T
Kardiol Pol; 2016; 74(9):1016-24. PubMed ID: 27112942
[TBL] [Abstract][Full Text] [Related]
15. [Are the newer antihypertensive agents better and more effective than diuretics?].
Landmark K
Tidsskr Nor Laegeforen; 2001 Feb; 121(6):701-5. PubMed ID: 11293353
[TBL] [Abstract][Full Text] [Related]
16. 50 years of thiazides: should thiazide diuretics be considered third-line hypertension treatment?
Brown A; Captain B
Am J Ther; 2011 Nov; 18(6):e244-54. PubMed ID: 21436766
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension.
Levi-Marpillat N; Macquin-Mavier I; Tropeano AI; Parati G; Maison P
Hypertens Res; 2014 Jun; 37(6):585-90. PubMed ID: 24671016
[TBL] [Abstract][Full Text] [Related]
18. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
Talbert RL
J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
[TBL] [Abstract][Full Text] [Related]
19. Calcium channel blockers versus other classes of drugs for hypertension.
Chen N; Zhou M; Yang M; Guo J; Zhu C; Yang J; Wang Y; Yang X; He L
Cochrane Database Syst Rev; 2010 Aug; (8):CD003654. PubMed ID: 20687074
[TBL] [Abstract][Full Text] [Related]
20. Association of Race/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member Report.
Colvin CL; King JB; Oparil S; Wright JT; Ogedegbe G; Mohanty A; Hardy ST; Huang L; Hess R; Muntner P; Bress A
JAMA Netw Open; 2020 Nov; 3(11):e2025127. PubMed ID: 33206191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]